Patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) and a history of frequent ‘attacks’ who were given a medicine called astegolimab reported an increase in health-related quality of life compared to those on a placebo, according to findings from a study published in the Lancet Respiratory Medicine.
Just one in six (18%) healthcare workers thought mandatory vaccinations were the best solution to encourage more frontline staff to have a Covid-19 jab, finds new research led by UCL and the University of Leicester.Read More
A stronger association exists between deaths from COVID-19 and obesity in people of Black, South Asian and other ethnic minority groups than in White people, research supported by ARC East Mildands and published in the journal Nature Communications demonstrates. Read More
Research in Leicester has been highlighted in a new report from the Medical Schools Council (MSC): Responding to a pandemic: UK universities’ response to COVID-19.Read More
A medicine licensed to treat psoriasis worsened symptoms in patients with severe asthma, according to trial results published today in the New England Journal of Medicine.Read More
New research in Leicester, which has been funded by the British Heart Foundation (BHF), could help understand how heart failure can develop in people living with Type 2 diabetes.Read More